Skip to main content
Clinical Trials/NCT06676306
NCT06676306
Recruiting
Not Applicable

Patient and Caregiver Priorities in Neuro-Oncology Care

Mayo Clinic1 site in 1 country80 target enrollmentApril 24, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Malignant Central Nervous System Neoplasm
Sponsor
Mayo Clinic
Enrollment
80
Locations
1
Primary Endpoint
Patient experience
Status
Recruiting
Last Updated
6 months ago

Overview

Brief Summary

This study is being done to identify patient and caregiver burdens regarding their experience with diagnosis and treatment of CNS tumors. These results will help doctors find areas where patients and caregivers may need more support.

Detailed Description

PRIMARY OBJECTIVES: I. Describe the patient experience and characterize the symptom burden related to primary or metastatic central nervous system tumors. II. Describe the caregiver experience and caregiver needs related to patients with primary or metastatic central nervous system tumors. III. Establish which interventional treatment outcomes are important to patients and caregivers, within a wider understanding of their lived experience with CNS tumors and their treatment. OUTLINE: This is an observational study. Patients and their caregivers participate in interviews on study. Patients also have their medical records reviewed on study.

Registry
clinicaltrials.gov
Start Date
April 24, 2024
End Date
April 30, 2026
Last Updated
6 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • \* Age ≥ 18 years.
  • Diagnosis of primary or metastatic CNS tumor with a primary caregiver, should patient wish to involve one.
  • Willing and able to participate in a semi-structured interview lasting approximately 60 minutes. Dyad interviews conducted for participants who elect to involve a caregiver.
  • Willing and able to participate in a single follow-up interview. Dyad follow up interviews conducted for participants who elect to involve a caregiver.

Exclusion Criteria

  • \* Uncontrolled and/or intercurrent illness which limits participation in study interview.
  • Vulnerable populations: pregnant or nursing persons, prisoners, or persons lacking capacity for understanding.
  • Unable to read and speak English.
  • Note: English does not need to be primary language.

Outcomes

Primary Outcomes

Patient experience

Time Frame: Up to 6 months

Participant and caregiver interviews will be analyzed qualitatively and reported descriptively. Interviews will be analyzed to describe the patient experience related to primary or metastatic central nervous system (CNS) tumors.

Symptom burden related to primary or metastatic central nervous system tumors

Time Frame: Up to 6 months

Participant and caregiver interviews will be analyzed qualitatively and reported descriptively. Interviews will be analyzed to characterize the symptom burden related to primary or metastatic central nervous system (CNS) tumors.

Caregiver experience

Time Frame: Up to 6 months

Patient and caregiver interviews will be analyzed qualitatively using thematic analysis and reported descriptively. Interviews will be analyzed to characterize the caregiver experience related to primary or metastatic CNS tumors.

Caregiver needs

Time Frame: Up to 6 months

Patient and caregiver interviews will be analyzed qualitatively using thematic analysis and reported descriptively. Interviews will be analyzed to characterize caregiver needs related to primary or metastatic CNS tumors.

Importance of treatment outcomes

Time Frame: Up to 6 months

Patient and caregiver interviews will be analyzed qualitatively using thematic analysis and reported descriptively. Interviews will be analyzed to establish which interventional treatment outcomes are important to patients and caregivers, within a wider understanding of their lived experience with CNS tumors and their treatment

Study Sites (1)

Loading locations...

Similar Trials